Peter ME - Search Results

1

CD95/Fas Increases Stemness in Cancer Cells by Inducing a STAT1-Dependent Type I Interferon Response.

Qadir AS, Ceppi P, Brockway S, Law C, Mu L, Khodarev NN, Kim J, Zhao JC, Putzbach W, Murmann AE, Chen Z, Chen W, Liu X, Salomon AR, Liu H, Weichselbaum RR, Yu J, Peter ME. Qadir AS, et al. Among authors: peter me. Cell Rep. 2017 Mar 7;18(10):2373-2386. doi: 10.1016/j.celrep.2017.02.037. Cell Rep. 2017. PMID: 28273453 Free PMC article.

2

FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death--inducing signaling complex.

Muzio M, Chinnaiyan AM, Kischkel FC, O'Rourke K, Shevchenko A, Ni J, Scaffidi C, Bretz JD, Zhang M, Gentz R, Mann M, Krammer PH, Peter ME, Dixit VM. Muzio M, et al. Among authors: peter me. Cell. 1996 Jun 14;85(6):817-27. doi: 10.1016/s0092-8674(00)81266-0. Cell. 1996. PMID: 8681377 Free article.

3

Molecular ordering of the initial signaling events of CD95.

Algeciras-Schimnich A, Shen L, Barnhart BC, Murmann AE, Burkhardt JK, Peter ME. Algeciras-Schimnich A, et al. Among authors: peter me. Mol Cell Biol. 2002 Jan;22(1):207-20. doi: 10.1128/MCB.22.1.207-220.2002. Mol Cell Biol. 2002. PMID: 11739735 Free PMC article.

4

The CD95(APO-1/Fas) DISC and beyond.

Peter ME, Krammer PH. Peter ME, et al. Cell Death Differ. 2003 Jan;10(1):26-35. doi: 10.1038/sj.cdd.4401186. Cell Death Differ. 2003. PMID: 12655293 Review.

5

Actin dependent CD95 internalization is specific for Type I cells.

Algeciras-Schimnich A, Peter ME. Algeciras-Schimnich A, et al. Among authors: peter me. FEBS Lett. 2003 Jul 10;546(2-3):185-8. doi: 10.1016/s0014-5793(03)00558-1. FEBS Lett. 2003. PMID: 12832037 Free article.

6

The CD95 type I/type II model.

Barnhart BC, Alappat EC, Peter ME. Barnhart BC, et al. Among authors: peter me. Semin Immunol. 2003 Jun;15(3):185-93. doi: 10.1016/s1044-5323(03)00031-9. Semin Immunol. 2003. PMID: 14563117 Review.

7

CD95 ligand induces motility and invasiveness of apoptosis-resistant tumor cells.

Barnhart BC, Legembre P, Pietras E, Bubici C, Franzoso G, Peter ME. Barnhart BC, et al. Among authors: peter me. EMBO J. 2004 Aug 4;23(15):3175-85. doi: 10.1038/sj.emboj.7600325. Epub 2004 Jul 22. EMBO J. 2004. PMID: 15272306 Free PMC article.

8

The relevance of NF-kappaB for CD95 signaling in tumor cells.

Legembre P, Barnhart BC, Peter ME. Legembre P, et al. Among authors: peter me. Cell Cycle. 2004 Oct;3(10):1235-9. doi: 10.4161/cc.3.10.1194. Epub 2004 Oct 26. Cell Cycle. 2004. PMID: 15467462

9

CD95 apoptosis resistance in certain cells can be overcome by noncanonical activation of caspase-8.

Barnhart BC, Pietras EM, Algeciras-Schimnich A, Salmena L, Sayama K, Hakem R, Peter ME. Barnhart BC, et al. Among authors: peter me. Cell Death Differ. 2005 Jan;12(1):25-37. doi: 10.1038/sj.cdd.4401509. Cell Death Differ. 2005. PMID: 15499374

10

Does CD95 have tumor promoting activities?

Peter ME, Legembre P, Barnhart BC. Peter ME, et al. Biochim Biophys Acta. 2005 May 25;1755(1):25-36. doi: 10.1016/j.bbcan.2005.01.001. Epub 2005 Jan 27. Biochim Biophys Acta. 2005. PMID: 15907590 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

200 results

Search Page